Exelixis Clinical Site #4

Atlanta, Georgia 30322

0 studies enrolling now · 2 studies all time

What they study most

Epithelial Ovarian Cancer, Hepatocellular Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer, Neoplasm Malignant, Triple Negative Breast Cancer

Studies at this site

• Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy — Running, not enrolling
• Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101) — Stopped early